Geron (GERN) EBITDA Margin: 2010-2025
Historic EBITDA Margin for Geron (GERN) over the last 16 years, with Sep 2025 value amounting to -29.40%.
- Geron's EBITDA Margin rose 7040.00% to -29.40% in Q3 2025 from the same period last year, while for Sep 2025 it was -32.22%, marking a year-over-year increase of 67324.00%. This contributed to the annual value of -194.29% for FY2024, which is 8163862.00% up from last year.
- Latest data reveals that Geron reported EBITDA Margin of -29.40% as of Q3 2025, which was down 15.78% from -25.40% recorded in Q2 2025.
- Over the past 5 years, Geron's EBITDA Margin peaked at -25.40% during Q2 2025, and registered a low of -236,039.13% during Q4 2023.
- In the last 3 years, Geron's EBITDA Margin had a median value of -7,860.88% in 2024 and averaged -60,152.98%.
- As far as peak fluctuations go, Geron's EBITDA Margin slumped by 19,531,000bps in 2023, and later spiked by 23,600,569bps in 2024.
- Geron's EBITDA Margin (Quarterly) stood at -2,979.04% in 2021, then crashed by 3,775,009bps to -40,729.13% in 2022, then tumbled by 19,531,000bps to -236,039.13% in 2023, then spiked by 23,600,569bps to -33.44% in 2024, then skyrocketed by 7,040bps to -29.40% in 2025.
- Its EBITDA Margin stands at -29.40% for Q3 2025, versus -25.40% for Q2 2025 and -42.18% for Q1 2025.